SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000902664-20-001689
Filing Date
2020-04-01
Accepted
2020-04-01 09:37:43
Documents
1

Document Format Files

Seq Description Document Type Size
1 CELLULAR BIOMEDICINE GROUP, INC. p20-0833sc13da.htm SC 13D/A 65374
  Complete submission text file 0000902664-20-001689.txt   67144
Mailing Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 11TH FLOOR NEW YORK NY 10105 (347) 905 5663
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82437 | Film No.: 20763996
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address PO BOX 472, 2ND FLOOR, HARBOUR PLACE 103 SOUTH CHURCH STREET, GEORGE TOWN GRAND CAYMAN E9 KY1-1106
Business Address PO BOX 472, 2ND FLOOR, HARBOUR PLACE 103 SOUTH CHURCH STREET, GEORGE TOWN GRAND CAYMAN E9 KY1-1106 86 21 5019 8835
TF Venture Capital Management Co., Ltd. (Filed by) CIK: 0001801706 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9
Type: SC 13D/A